{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:42:15Z","timestamp":1769067735098,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.anpede.2025.504063","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:20:00Z","timestamp":1768047600000},"page":"504063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-HLA risk variants in a type 1 diabetes pediatric population: Clinical and autoimmune profiles"],"prefix":"10.1016","volume":"104","author":[{"given":"Miriam","family":"D\u00edez Blanco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"P\u00e9rez Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Encarnaci\u00f3n","family":"Donoso Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Santiesteban Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Mart\u00ednez-Bad\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Colino Alcol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purificaci\u00f3n","family":"Ros P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10138","key":"10.1016\/j.anpede.2025.504063_bib0005","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.anpede.2025.504063_bib0010","series-title":"IDF Atlas Reports","article-title":"Type 1 diabetes numbers in children and adults","author":"Ogle","year":"2022"},{"key":"10.1016\/j.anpede.2025.504063_bib0015","unstructured":"Type 1 Diabetes Index. T1D Index, Espa\u00f1a. [Accessed 6 August 2024]. Available from: https:\/\/www.t1dindex.org\/countries\/spain\/."},{"key":"10.1016\/j.anpede.2025.504063_bib0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.anpede.2025.504063_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.618213","article-title":"Type 1 diabetes and autoimmune thyroid disease-the genetic link","volume":"12","author":"Frommer","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.anpede.2025.504063_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/labmed\/lmad079","article-title":"Study of the diagnostic efficiency of anti-ZnT8 autoantibodies for type 1 diabetes in pediatric patients","volume":"55","author":"Fuentes-Cantero","year":"2024","journal-title":"Lab Med"},{"key":"10.1016\/j.anpede.2025.504063_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mce.2018.06.002","article-title":"The genetic architecture of type 1 diabetes mellitus","volume":"477","author":"Nyaga","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.anpede.2025.504063_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909020","article-title":"Non-HLA gene polymorphisms in the pathogenesis of type 1 diabetes: phase and endotype specific effects","volume":"13","author":"Laine","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.anpede.2025.504063_bib0045","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1007\/s00125-020-05248-8","article-title":"Next steps in the identification of gene targets for type 1 diabetes","volume":"63","author":"Grant","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.anpede.2025.504063_bib0050","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/imcb.12438","article-title":"De-coding genetic risk variants in type 1 diabetes","volume":"99","author":"Shapiro","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.anpede.2025.504063_bib0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cei\/uxad002","article-title":"CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients","volume":"211","author":"Vandewalle","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anpede.2025.504063_bib0060","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2337\/db14-1497","article-title":"Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study","volume":"64","author":"T\u00f6rn","year":"2015","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.anpede.2025.504063_bib0065","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dcs15-2003","article-title":"Shared genetic basis for type 1 diabetes, islet autoantibodies, and autoantibodies associated with other immune-mediated diseases in families with type 1 diabetes","volume":"38","author":"Brorsson","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.anpede.2025.504063_bib0070","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.anpede.2025.504063_bib0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.anpede.2025.504063_bib0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08916930701510848","article-title":"PTPN22: its role in SLE and autoimmunity","volume":"40","author":"Chung","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.anpede.2025.504063_bib0085","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1210\/jc.2017-02577","article-title":"PTPN22 and CTLA-4 polymorphisms are associated with polyglandular autoimmunity","volume":"103","author":"Houcken","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anpede.2025.504063_bib0090","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/jc.2016-4003","article-title":"Can non-HLA single nucleotide polymorphisms help stratify risk in trialnet relatives at risk for type 1 diabetes?","volume":"102","author":"Steck","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anpede.2025.504063_bib0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1157\/13114465","article-title":"Impacto del diagn\u00f3stico de la enfermedad cel\u00edaca en el control metab\u00f3lico de la diabetes tipo 1","volume":"68","author":"N\u00f3voa Medina","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpede.2025.504063_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humimm.2008.12.007","article-title":"Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children","volume":"70","author":"Balic","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.anpede.2025.504063_bib0105","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.anpede.2025.504063_bib0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.anpede.2025.504063_bib0115","unstructured":"CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 - No Study Results Posted ClinicalTrials.gov. [Accessed 6 August 2024]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/results\/NCT01773707."},{"key":"10.1016\/j.anpede.2025.504063_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/db19-0329","article-title":"Longitudinal pattern of first-phase insulin response is associated with genetic variants outside the class II HLA region in children with multiple autoantibodies","volume":"69","author":"Koskinen","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.anpede.2025.504063_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.606171","article-title":"Can the FUT2 non-secretor phenotype associated with gut microbiota increase the children susceptibility for type 1 diabetes? A mini review","volume":"7","author":"Giampaoli","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.anpede.2025.504063_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.anpede.2025.504063_bib0135","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/db12-1398","article-title":"Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms","volume":"62","author":"Nguyen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.anpede.2025.504063_bib0140","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00125-023-05955-y","article-title":"Utility of genetic risk scores in type 1 diabetes","volume":"66","author":"Luckett","year":"2023","journal-title":"Diabetologia"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925004648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287925004648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:24:39Z","timestamp":1769012679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287925004648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2341287925004648"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2025.504063","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-HLA risk variants in a type 1 diabetes pediatric population: Clinical and autoimmune profiles","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2025.504063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2025.504063","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"504063"}}